New York, United States, March 15, 2024 (GLOBE NEWSWIRE) -- The Global Self Injection Device Market Size is to Grow from USD 6.5 Billion in 2023 to USD 10.7 Billion by 2033, at a Compound Annual ...
Dublin, Jan. 03, 2025 (GLOBE NEWSWIRE) -- The "Self-injection Devices Market by Product, Usability, Application, Distribution Channel, and Region" report has been added to ResearchAndMarkets.com's ...
The issuer is solely responsible for the content of this announcement. Driving subcutaneous self-injection of large volume doses: SCHOTT Pharma launches large format ready-to-use cartridges for ...
Acting, At-Home Treatment for Inflammatory Acne Lesions to be Administered with the ClearPen™, its Proprietary Intradermal ...
The Global Self-injection Devices Market was valued at approximately USD 6.98 billion in 2022 and is projected to grow at a healthy rate of more than 5.7% CAGR during the forecast period 2023-2030.
VYVGART, the first-in-class FcRn blocker, now offers three administration options, including self-injection with a prefilled syringe Self-injection provides gMG and CIDP patients with flexibility for ...
VYVGART, the first-in-class FcRn blocker, now offers three administration options, including self-injection with a prefilled syringe Self-injection provides gMG and CIDP patients with flexibility for ...
Cabotegravir and rilpivirine (cabenuva), the only complete HIV treatment regimen delivered by injection, could be given by intramuscular injection to the thigh rather than the gluteal muscles, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results